Murray L Barclay (Murray Barclay, M L Barclay)

Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Top Venues

Internal medicine journal

Alimentary pharmacology & therapeutics

Therapeutic drug monitoring

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Lisa K Stamp, Paula E Keating, Christopher M A Frampton, Murray L Barclay, Niamh C Fanning, Melanie J Millier, Paul A Hessian, John L O'Donnell
Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study. The Journal of rheumatology 51 (3) (2024)
Lisa K Stamp, Paula E Keating, Christopher M A Frampton, Murray L Barclay, Niamh C Fanning, Melanie J Millier, Paul A Hessian, John L O'Donnell
Relationship Between Adalimumab Concentrations, Antidrug Antibodies, and Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Observational Study. The Journal of rheumatology 51 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring (2024)
Murray L Barclay, Lisa K Stamp
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease. Alimentary pharmacology & therapeutics 59 (1) (2023)
Murray L Barclay, Lisa K Stamp
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease. Alimentary pharmacology & therapeutics 59 (1) (2023)
Murray L Barclay, Lisa K Stamp
Editorial: Monitoring methotrexate polyglutamates in Crohn's disease. Alimentary pharmacology & therapeutics 59 (1) (2023)
Paula E Keating, Barry D Hock, Stewart M Smith, Paul Ken Leong Chin, John L O'Donnell, Murray L Barclay
Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing. Internal medicine journal 53 (11) (2023)
Millie Y Wang, Murray L Barclay, Paul Ken Leong Chin, Matthew P Doogue
Changes in inpatient medicine prescribing during COVID-19 lockdown. Internal medicine journal (2022)
Millie Y Wang, Murray L Barclay, Paul Ken Leong Chin, Matthew P Doogue
Changes in inpatient medicine prescribing during COVID-19 lockdown. Internal medicine journal (2022)
Millie Y Wang, Murray L Barclay, Paul Ken Leong Chin, Matthew P Doogue
Changes in inpatient medicine prescribing during Covid-19 lockdown. Internal medicine journal (2022)
Emma K Flanagan, Emily K Wright, Winita Hardikar, Miles Patrick Sparrow, William R Connell, Michael A Kamm, Peter De Cruz, Steven J Brown, Alexander Thompson, Anthea Greenway, Ian Westley, Murray L Barclay, Alyson L Ross, Katerina V Kiburg, Sally J Bell, null null
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates. Alimentary pharmacology & therapeutics 53 (7) (2021)
Pepijn W A Thomas, Paul Ken Leong Chin, Murray L Barclay
A nationwide survey on therapeutic drug monitoring of anti-tumour necrosis factor agents for inflammatory bowel disease. Internal medicine journal 51 (3) (2021)
Syarihan Karim, Jennifer M Butler, Murray L Barclay
A 1 g dose of intravenous iron is sufficient to treat iron deficiency anaemia. Internal medicine journal 50 (12) (2021)
Paul Ken Leong Chin, QianYi Chuah, Amanda M Crawford, Olivia R Clendon, Philip G Drennan, Judith M Dalrymple, Murray L Barclay, Matthew P Doogue
Clinical decision support in a hospital electronic prescribing system informed by local data: experience at a tertiary New Zealand centre. Internal medicine journal 50 (10) (2021)
Amarylle S van Doorn, Berrie Meijer, Chris M A Frampton, Murray L Barclay, Nanne K H de Boer
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission. Alimentary pharmacology & therapeutics 52 (8) (2020)
Murray L Barclay, Shwan Karim, Esther T Johanna Helms, Paula E Keating, Barry D Hock, Lisa K Stamp, Michael Schultz
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays. Internal medicine journal 49 (4) (2020)
Murray L Barclay, L K Stamp
Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease. Alimentary pharmacology & therapeutics 47 (4) (2019)
Antony B Friedman, S J Brown, P Bampton, Murray L Barclay, A Chung, F A Macrae, J McKenzie, J Reynolds, P R Gibson, Stephen Hanauer, Miles Patrick Sparrow
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study). Alimentary pharmacology & therapeutics 47 (8) (2018)